Adam J. FountainManaging Director, Broadmark Capital

    Mr. Fountain’s responsibilities at Broadmark include investor and client sourcing, and transaction management across all of Broadmark’s focus areas including life sciences, technology, new media, middle market, real estate, telecommunications and financial services. His current interests include life science companies that have demonstrated proof of concept, particularly drugs with clinical data and devices with at least animal data, and some mitigation of risk, e.g. shortened regulatory paths, 505(b)2, etc. Areas of interest in technology include SaaS, new media, and any revenue generating high growth companies. Responsibilities also include all activities related to Broadmark’s merchant banking function: identifying and qualifying potential direct investments and producing Broadmark white papers. In addition to these responsibilities, Mr. Fountain is a part owner of Pyatt Broadmark Management, LLC and responsible for their investor relations and fund management. He also has a significant support role for Broadmark relating to regulatory compliance.

    Mr. Fountain has had a significant or lead role in the following engagements (in no particular order): Pyatt Broadmark Management, Global Voyages Group, FedTax, AVM, MGT, SRS Medical, PhysioSonics, Generic Medical Devices, HipCricket, Omeros, XShares, Sound Pharmaceuticals, Zynex Medical, MediQuest Therapeutics, CardioMetrix and Shoreline among others. Mr. Fountain originally joined Broadmark in 2003 as an Associate focused on client sourcing and transaction management in the life sciences sector.

    Prior to joining Broadmark, Mr. Fountain was an Associate at L.E.K. Consulting in Los Angeles, CA from 2001 through 2003, an international strategic consulting firm headquartered in London. While at L.E.K., he worked primarily in the life sciences practice. Key projects included developing a product marketing and distribution strategy for an established European pharmaceutical company, formulating a product development and partnering strategy for a start-up biotechnology company, and preparing for the likely adoption of a new product in the medical device industry.

    Mr. Fountain graduated with a B.A. in International Relations from Stanford University, Minor in German Studies in 2001. He holds Series 7, Series 63, Series 66 and Series 79 FINRA registrations. Outside of Broadmark, Mr. Fountain was a co-founder of WINGS: The Washington Medical Technology Angel Network, and formerly served as a Director. In addition to his role at WINGS, he has served on the Executive Committee for the WBBA’s annual life science conference for several years. He is active in his church and resides north of Seattle with his wife, Emily, and their son, Samuel. He enjoys riding his bike, cooking, brewing, fantasy baseball, and beekeeping.

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Not readable? Change text.